James Chapman Ross, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Emphysema | 15 | 2023 | 684 | 1.810 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 25 | 2023 | 3204 | 1.370 |
Why?
|
| Lung | 29 | 2023 | 10000 | 1.170 |
Why?
|
| Tomography, X-Ray Computed | 46 | 2022 | 20570 | 1.060 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 12 | 2019 | 1222 | 0.920 |
Why?
|
| Smoking | 24 | 2023 | 9053 | 0.850 |
Why?
|
| Pattern Recognition, Automated | 6 | 2020 | 997 | 0.780 |
Why?
|
| Forced Expiratory Volume | 13 | 2023 | 1814 | 0.560 |
Why?
|
| Mucin-5B | 5 | 2018 | 148 | 0.550 |
Why?
|
| Respiratory Function Tests | 13 | 2021 | 1682 | 0.530 |
Why?
|
| Radiographic Image Enhancement | 5 | 2010 | 876 | 0.520 |
Why?
|
| Pulmonary Artery | 6 | 2021 | 1927 | 0.420 |
Why?
|
| Lung Diseases, Interstitial | 6 | 2017 | 918 | 0.380 |
Why?
|
| Radiography, Thoracic | 5 | 2024 | 1302 | 0.380 |
Why?
|
| Bronchiectasis | 2 | 2023 | 139 | 0.370 |
Why?
|
| Emphysema | 3 | 2023 | 238 | 0.360 |
Why?
|
| Pulmonary Veins | 4 | 2021 | 743 | 0.340 |
Why?
|
| Algorithms | 9 | 2020 | 14031 | 0.340 |
Why?
|
| Artifacts | 3 | 2019 | 1911 | 0.310 |
Why?
|
| Solitary Pulmonary Nodule | 2 | 2007 | 278 | 0.280 |
Why?
|
| Ultrasonic Therapy | 1 | 2008 | 215 | 0.260 |
Why?
|
| Pectoralis Muscles | 2 | 2018 | 85 | 0.260 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2008 | 266 | 0.250 |
Why?
|
| Lung Diseases | 3 | 2017 | 1909 | 0.250 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2019 | 9000 | 0.230 |
Why?
|
| Bronchography | 2 | 2015 | 75 | 0.230 |
Why?
|
| Heart Ventricles | 4 | 2020 | 3807 | 0.220 |
Why?
|
| Polymorphism, Genetic | 4 | 2017 | 4243 | 0.210 |
Why?
|
| Total Lung Capacity | 5 | 2015 | 149 | 0.200 |
Why?
|
| Vital Capacity | 5 | 2019 | 971 | 0.200 |
Why?
|
| Sensitivity and Specificity | 14 | 2017 | 14666 | 0.200 |
Why?
|
| Molecular Epidemiology | 2 | 2022 | 469 | 0.190 |
Why?
|
| Models, Statistical | 2 | 2013 | 5079 | 0.180 |
Why?
|
| Reproducibility of Results | 16 | 2019 | 20098 | 0.180 |
Why?
|
| Fluoroscopy | 1 | 2005 | 947 | 0.180 |
Why?
|
| Blood Vessels | 2 | 2018 | 1113 | 0.170 |
Why?
|
| Prosthesis Implantation | 1 | 2005 | 592 | 0.170 |
Why?
|
| Pulmonary Heart Disease | 1 | 2019 | 34 | 0.170 |
Why?
|
| Aorta | 2 | 2019 | 2042 | 0.170 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2005 | 952 | 0.170 |
Why?
|
| Severity of Illness Index | 14 | 2019 | 15842 | 0.170 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 2 | 2017 | 515 | 0.160 |
Why?
|
| Phlebography | 1 | 2019 | 326 | 0.150 |
Why?
|
| Artificial Intelligence | 3 | 2023 | 2578 | 0.150 |
Why?
|
| Longitudinal Studies | 9 | 2021 | 14605 | 0.140 |
Why?
|
| Disease Progression | 6 | 2023 | 13506 | 0.140 |
Why?
|
| Image Enhancement | 1 | 2008 | 2885 | 0.140 |
Why?
|
| Trachea | 2 | 2015 | 1089 | 0.140 |
Why?
|
| Databases, Factual | 3 | 2018 | 7967 | 0.130 |
Why?
|
| Cardiac Volume | 1 | 2017 | 197 | 0.130 |
Why?
|
| Middle Aged | 39 | 2023 | 220895 | 0.130 |
Why?
|
| Humans | 64 | 2024 | 761504 | 0.130 |
Why?
|
| Imaging, Three-Dimensional | 5 | 2019 | 4063 | 0.130 |
Why?
|
| Vasodilation | 1 | 2019 | 962 | 0.130 |
Why?
|
| Aged | 33 | 2021 | 169289 | 0.120 |
Why?
|
| Vasodilator Agents | 1 | 2019 | 973 | 0.120 |
Why?
|
| Amyloid Neuropathies, Familial | 1 | 2017 | 151 | 0.120 |
Why?
|
| Ventricular Function | 1 | 2017 | 406 | 0.120 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2008 | 3357 | 0.120 |
Why?
|
| Asthma | 3 | 2019 | 6234 | 0.120 |
Why?
|
| Heart Diseases | 2 | 2017 | 2781 | 0.120 |
Why?
|
| Spirometry | 4 | 2023 | 929 | 0.120 |
Why?
|
| Male | 43 | 2024 | 360804 | 0.110 |
Why?
|
| Respiratory Muscles | 1 | 2014 | 142 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 4 | 2018 | 5789 | 0.110 |
Why?
|
| Aortography | 1 | 2015 | 421 | 0.110 |
Why?
|
| DNA | 2 | 2018 | 7212 | 0.110 |
Why?
|
| Principal Component Analysis | 2 | 2013 | 943 | 0.110 |
Why?
|
| Inhalation | 1 | 2013 | 143 | 0.110 |
Why?
|
| Exhalation | 1 | 2013 | 181 | 0.100 |
Why?
|
| Stents | 1 | 2005 | 3179 | 0.100 |
Why?
|
| Female | 45 | 2024 | 392644 | 0.100 |
Why?
|
| Pneumonia | 1 | 2024 | 2143 | 0.100 |
Why?
|
| Aged, 80 and over | 14 | 2018 | 58976 | 0.100 |
Why?
|
| Respiratory Tract Diseases | 1 | 2018 | 750 | 0.100 |
Why?
|
| Liver Neoplasms | 1 | 2008 | 4320 | 0.100 |
Why?
|
| Organ Size | 4 | 2019 | 2254 | 0.100 |
Why?
|
| Subcutaneous Fat | 1 | 2014 | 393 | 0.090 |
Why?
|
| Bronchi | 1 | 2015 | 845 | 0.090 |
Why?
|
| Fibrinogen | 1 | 2014 | 888 | 0.090 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2016 | 628 | 0.090 |
Why?
|
| Absorptiometry, Photon | 1 | 2017 | 1738 | 0.090 |
Why?
|
| Nitric Oxide | 1 | 2019 | 2135 | 0.090 |
Why?
|
| Densitometry | 1 | 2010 | 151 | 0.090 |
Why?
|
| Respiratory Mechanics | 2 | 2011 | 699 | 0.080 |
Why?
|
| Proportional Hazards Models | 6 | 2022 | 12463 | 0.080 |
Why?
|
| Cause of Death | 2 | 2018 | 3683 | 0.080 |
Why?
|
| Observer Variation | 3 | 2017 | 2606 | 0.080 |
Why?
|
| Regression Analysis | 5 | 2019 | 6343 | 0.080 |
Why?
|
| Cohort Studies | 11 | 2023 | 41487 | 0.080 |
Why?
|
| Bayes Theorem | 1 | 2017 | 2330 | 0.080 |
Why?
|
| Phenotype | 4 | 2020 | 16591 | 0.080 |
Why?
|
| Case-Control Studies | 4 | 2019 | 22176 | 0.070 |
Why?
|
| Coronary Artery Disease | 2 | 2016 | 6403 | 0.070 |
Why?
|
| Logistic Models | 6 | 2019 | 13255 | 0.070 |
Why?
|
| Calcinosis | 1 | 2015 | 1469 | 0.070 |
Why?
|
| Inflammasomes | 1 | 2012 | 526 | 0.070 |
Why?
|
| Computer Systems | 1 | 2008 | 470 | 0.070 |
Why?
|
| Arteriosclerosis | 1 | 2010 | 1055 | 0.070 |
Why?
|
| Magnetic Resonance Imaging, Cine | 3 | 2017 | 1050 | 0.060 |
Why?
|
| Software | 1 | 2020 | 4434 | 0.060 |
Why?
|
| Multivariate Analysis | 5 | 2019 | 12059 | 0.060 |
Why?
|
| Aortic Diseases | 1 | 2010 | 735 | 0.060 |
Why?
|
| Adiposity | 1 | 2014 | 1878 | 0.060 |
Why?
|
| Airway Remodeling | 2 | 2016 | 133 | 0.060 |
Why?
|
| Adult | 12 | 2024 | 221177 | 0.060 |
Why?
|
| Predictive Value of Tests | 5 | 2019 | 15266 | 0.050 |
Why?
|
| Systems Integration | 1 | 2005 | 426 | 0.050 |
Why?
|
| Prospective Studies | 6 | 2023 | 54425 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 3826 | 0.050 |
Why?
|
| Lung Volume Measurements | 2 | 2015 | 375 | 0.050 |
Why?
|
| Pulmonary Diffusing Capacity | 2 | 2013 | 94 | 0.050 |
Why?
|
| Radioisotopes | 1 | 2023 | 499 | 0.050 |
Why?
|
| Subtraction Technique | 1 | 2005 | 512 | 0.050 |
Why?
|
| Risk Assessment | 3 | 2018 | 23995 | 0.050 |
Why?
|
| Linear Models | 3 | 2019 | 5871 | 0.050 |
Why?
|
| Motion | 1 | 2005 | 779 | 0.050 |
Why?
|
| Movement | 1 | 2008 | 1478 | 0.050 |
Why?
|
| Exercise Tolerance | 2 | 2019 | 836 | 0.040 |
Why?
|
| Young Adult | 4 | 2021 | 59243 | 0.040 |
Why?
|
| United States | 8 | 2021 | 72334 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2019 | 17904 | 0.040 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2006 | 1192 | 0.040 |
Why?
|
| Survival Rate | 3 | 2018 | 12725 | 0.040 |
Why?
|
| Prevalence | 4 | 2017 | 15732 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2012 | 4936 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 15936 | 0.040 |
Why?
|
| Hospitals, Veterans | 1 | 2020 | 395 | 0.040 |
Why?
|
| Tidal Volume | 2 | 2011 | 488 | 0.040 |
Why?
|
| Genotype | 3 | 2018 | 12990 | 0.040 |
Why?
|
| Pulmonary Fibrosis | 2 | 2012 | 505 | 0.040 |
Why?
|
| Iceland | 1 | 2017 | 184 | 0.040 |
Why?
|
| Technetium Tc 99m Sestamibi | 1 | 2017 | 174 | 0.040 |
Why?
|
| Mortality | 2 | 2019 | 2901 | 0.040 |
Why?
|
| Cross-Sectional Studies | 4 | 2020 | 26125 | 0.030 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2005 | 1007 | 0.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2012 | 3245 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 2019 | 1157 | 0.030 |
Why?
|
| ROC Curve | 2 | 2017 | 3579 | 0.030 |
Why?
|
| Retrospective Studies | 6 | 2023 | 80636 | 0.030 |
Why?
|
| Risk Factors | 6 | 2021 | 74206 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2018 | 999 | 0.030 |
Why?
|
| Body Mass Index | 4 | 2015 | 12953 | 0.030 |
Why?
|
| Maximal Midexpiratory Flow Rate | 1 | 2015 | 76 | 0.030 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2019 | 474 | 0.030 |
Why?
|
| Echocardiography | 2 | 2017 | 4989 | 0.030 |
Why?
|
| Microcirculation | 1 | 2019 | 1273 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2008 | 5972 | 0.030 |
Why?
|
| Statistics as Topic | 2 | 2011 | 2358 | 0.030 |
Why?
|
| Boston | 2 | 2017 | 9326 | 0.030 |
Why?
|
| Muscle Strength | 1 | 2018 | 624 | 0.030 |
Why?
|
| Exercise Test | 1 | 2021 | 2127 | 0.030 |
Why?
|
| Spain | 1 | 2014 | 487 | 0.030 |
Why?
|
| Automation | 1 | 2015 | 586 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2019 | 2707 | 0.030 |
Why?
|
| Discriminant Analysis | 1 | 2013 | 222 | 0.030 |
Why?
|
| Liver | 1 | 2008 | 7529 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2017 | 2850 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 39106 | 0.020 |
Why?
|
| Residual Volume | 1 | 2011 | 41 | 0.020 |
Why?
|
| Caspase 1 | 1 | 2012 | 225 | 0.020 |
Why?
|
| Amyloidosis | 1 | 2017 | 817 | 0.020 |
Why?
|
| Bleomycin | 1 | 2012 | 494 | 0.020 |
Why?
|
| Bronchioles | 1 | 2010 | 30 | 0.020 |
Why?
|
| Prognosis | 3 | 2018 | 29625 | 0.020 |
Why?
|
| Normal Distribution | 1 | 2011 | 272 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 2759 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 8002 | 0.020 |
Why?
|
| Netherlands | 1 | 2014 | 2221 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2014 | 2281 | 0.020 |
Why?
|
| Pediatrics | 1 | 2024 | 3589 | 0.020 |
Why?
|
| Internationality | 1 | 2014 | 1001 | 0.020 |
Why?
|
| Models, Biological | 1 | 2005 | 9469 | 0.020 |
Why?
|
| Respiratory System | 1 | 2011 | 563 | 0.020 |
Why?
|
| Angiography | 1 | 2013 | 1595 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2012 | 1755 | 0.020 |
Why?
|
| Age of Onset | 1 | 2014 | 3305 | 0.020 |
Why?
|
| Acute Disease | 1 | 2018 | 7237 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 6484 | 0.020 |
Why?
|
| Sex Factors | 1 | 2020 | 10552 | 0.020 |
Why?
|
| Alleles | 1 | 2017 | 6863 | 0.020 |
Why?
|
| Lung Neoplasms | 2 | 2007 | 13380 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2019 | 3530 | 0.020 |
Why?
|
| Incidence | 2 | 2017 | 21353 | 0.020 |
Why?
|
| Airway Obstruction | 1 | 2010 | 661 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2017 | 10090 | 0.020 |
Why?
|
| Radiography | 1 | 2016 | 6965 | 0.010 |
Why?
|
| Body Composition | 1 | 2014 | 2426 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 3416 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2014 | 2639 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2017 | 6377 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2017 | 5496 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 4948 | 0.010 |
Why?
|
| Dyspnea | 1 | 2010 | 1347 | 0.010 |
Why?
|
| Infant | 1 | 2024 | 36192 | 0.010 |
Why?
|
| Child | 2 | 2024 | 80153 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2024 | 42230 | 0.010 |
Why?
|
| Contrast Media | 1 | 2014 | 5311 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2011 | 2691 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2019 | 12690 | 0.010 |
Why?
|
| Age Factors | 1 | 2016 | 18395 | 0.010 |
Why?
|
| Quality of Life | 1 | 2017 | 13367 | 0.010 |
Why?
|
| Comorbidity | 1 | 2009 | 10508 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 22169 | 0.010 |
Why?
|
| Adolescent | 1 | 2021 | 88319 | 0.010 |
Why?
|
| Neoplasms | 1 | 2016 | 22170 | 0.000 |
Why?
|
| Mice | 1 | 2012 | 81525 | 0.000 |
Why?
|
| Animals | 1 | 2012 | 168459 | 0.000 |
Why?
|